Summary
The FDA has proposed removing oral phenylephrine, a common ingredient in over-the-counter cold medicines like NyQuil and Sudafed, due to evidence that it is ineffective as a nasal decongestant.
The proposal follows a unanimous vote by FDA advisers last year, and recent studies showing less than 1% of the drug is absorbed into the bloodstream when taken orally.
The public comment period ends on May 7, after which the FDA may finalize the ban.
It’s the same here. The Therapeutic Goods Administration, our equivalent to the FDA, generally follows along with FDA regulations (though I don’t think that will continue from next year somehow).
Yeah, might be hard to follow FDA regulations when the FDA gets dismantled and no longer exists… eye twitch